Abstract
Brain metastases are often seen in Eastern-Asian lung adenocarcinoma in which most common oncogenic driver mutations are EGFR sensitive mutations or EML4- ALK fusions, occurring in about 60% patients. Elucidation of EGFR and ALK-driven mutation prognostic factors in patients with brain metastases has important clinical implications.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
